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Vascular compliance in sodium-sensitive and sodium-resistant
borderline hypertensive patients
PETRA DRAAIJER, MIRIAN J.F. KooL, Luc M.A.B. v BORTEL, FRED NIEMAN, PETER W. DE LEEUW,
JOHANNES P. VAN HOOFF, and KAREL M.L. LEUNISSEN
Vascular compliance in sodium-sensitive and sodium-resistant border-
line hypertensive patients. Recently, we demonstrated a reduction in the
compliance of the carotid, femoral and brachial arteries in sodium-
sensitive subjects who had consumed a regular sodium intake of approx-
imately 120 mmol per day, as compared to both sodium-resistant border-
line hypertensive subjects and normotensive controls. Venous compliance
was not different between the two borderline hypertensive groups and was
only slightly lesser than in controls. Large artery compliance was studied
using a non-invasive ultrasound vessel wall movement detector system,
while venous compliance was determined by means of strain gauge
plethysmography. The borderline hypertensive subjects were subsequently
treated with enalapril 10 mg/day, felodipine 5 mg/day or placebo during six
months. Despite similar reductions in blood pressure, enalapril induced a
significant increase of the muscular femoral and brachial artery compli-
ance, but not of the elastic carotid artery, while felodipine did not
influence large artery compliance at all in the sodium-sensitive group. The
effect of enalapril on muscular artery compliance was established through
a dose-dependent increase in distension and not through a change in
arterial diameter. Arterial compliance was not influenced by either of the
drugs in the resistant group. Venous compliance was also not altered by
the medication, In conclusion, femoral and brachial artery compliance in
sodium-sensitive borderline hypertensive subjects, which was found to be
lower than that of sodium-resistant subjects, improved with antihyperten-
sive treatment with enalapril but not with felodipine, despite the similar
reductions in blood pressure induced by both drugs. This finding implies
that firstly, reduced arterial compliance is caused by more than just blood
pressure elevation, and secondly, the renin-angiotensin system may play a
role in the reduced arterial compliance of sodium-sensitive subjects.
Recently, we demonstrated that under conditions of a regular
sodium intake of approximately 120 mmol sodium per day [1],
sodium-sensitive borderline hypertensive subjects display a re-
duced compliance of the carotid, femoral and brachial arteries as
compared to sodium-resistant patients and normotensive controls.
Furthermore, despite the slight increase in blood pressure, arte-
rial compliance in resistant subjects did not differ appreciably
from normal. The diminished compliance in the sensitive group
was the consequence of reduced arterial wall distension upon the
pulse wave since arterial diameter, blood pressure and pulse
pressure were similar in the sensitive and resistant groups.
The mechanisms underlying the difference in large artery
compliance remain elusive. It could be argued that differences in
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the activity of the renin-angiotensin system between sodium-
sensitive and sodium-resistant subjects play a role, as sodium
sensitivity has been linked to inadequate suppression of the renin
system after a sodium load [2]. In this respect, sodium-sensitive
hypertensive subjects are thought to exhibit an inappropriately
high intrarenal production of angiotensin II, while sodium-resis-
tant subjects do not [3]. Thus, it may be hypothesized that by
virtue of its vasocontrictor and/or growth promoting effects [4],
angiotensin II could be responsible for decreased arterial compli-
ance in sodium-sensitive subjects.
On the other hand, a disturbance in intracellular calcium
metabolism may induce stiffer arteries in sodium-sensitive sub-
jects. Indeed, in vascular smooth muscle cells a raised level of free
calcium may increase muscular tone, thereby contributing not
only to the pressor action of sodium, but also to increased vascular
stiffness. In this respect, it is relevant to note that in essential
hypertensive patients the pressure response to high sodium intake
correlates positively with the increase in lymphocytic intracellular
free calcium concentration [5].
The above-mentioned pathophysiologic considerations may not
only apply to arterial compliance, but also to venous compliance.
Takeshita and coworkers described a reduced venous compliance
in sodium-sensitive hypertensive subjects as compared to sodium-
resistant ones on a high sodium diet of 345 mmols per day [6]. In
our study population, venous compliance tended to be decreased
in the sodium-sensitive and resistant borderline hypertensive
subjects as compared to normotensive controls [1].
Based upon these considerations, treatment with either an
ACE-inhibitor or a calcium entry blocker may improve vascular
compliance. Therefore the aim of this study was to investigate the
effect of six months of treatment with either enalapril or felo-
dipine on the compliance of carotid, femoral and brachial arteries
in sodium-sensitive and -resistant borderline hypertensive sub-
jects. In addition, we measured venous compliance during enala-
pril and felodipine treatment to investigate whether these agents
confered any benefit on this variable.
Large artery compliance may be a major determinant of left
ventricular hypertrophy in hypertension [7]. The reduced large
artery compliance that was found in sodium-sensitive borderline
hypertensives may well be related to increased left ventricular
mass. Finally we determined echo-Doppler cardiographic mea-
surements, not only to study whether there are differences in left
ventricular mass between the groups and how pharmacological
intervention interferes, but also to study stroke volume, since
arterial distension and thus compliance depend on stroke volume.
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Methods
Patient characteristics
Forty-seven previously untreated borderline hypertensive pa-
tients were included in the study. Borderline hypertension was
defined as a diastolic blood pressure of 90 to 95 mm Hg and a
systolic blood pressure of 140 to 160 mm Hg [8]. All subjects were
20- to 45-year-old males and non-smokers. The patients were
recruited with the aid of general practitioners, blood banks and
local advertising. Besides the slight increase in blood pressure, all
subjects were in good health. Secondary hypertension was ex-
cluded on the basis of medical history, physical examination and
laboratory test results. The protocol of this study was approved by
the hospital's ethics committee, and informed consent was ob-
tained from all the participants before they entered the study.
Sodium-sensitivity assessment
The sodium-sensitivity status of the borderline hypertensives
was determined five weeks before the onset of this study. A diet
method was used in which the subjects consumed, at random
order, a low sodium diet, containing 20 mmol sodium per day or
a high sodium diet containing 220 mmol sodium per day during
one week, with the alternative diet during the following week. The
potassium content of both diets was 70 mmol per day. An
arbitrarily chosen cut-off point of 8 mm Hg difference in mean
arterial pressure between the end of the high sodium and the end
of the low sodium diet was taken as an index of sodium sensitivity.
The reproducibility of this approach was tested by restudying 10
subjects, approximately one year after the initial investigation. An
excellent agreement between the first and the second test was
found [9].
Protocol
After the initial study, that revealed the difference in arterial
compliance between the groups, the subjects were randomly and
in a double blind manner assigned to three treatment stategies:
enalapril 10 mg/day, felodipine 5 mg/day or placebo. Before and
again after three months of therapy, at the end of the treatment
period at six months, and three months after stopping treatment,
the subjects were investigated. During the week preceding the day
at which the investigations took place, they consumed a diet
containing 120 mmol sodium and 70 mmol potassium per day,
while 24 hour urines were collected in order to estimate adher-
ence to the diet.
The subjects used a light breakfast and entered the hospital at
8:00 a.m., at the days of the investigations. At first, body weight
was measured. All subsequent investigations were performed in
supine position, in a temperature controlled room of approxi-
mately 24°C. Blood pressure was measured after at least 15
minutes of rest. Systolic and diastolic pressure were measured
every five minutes for half an hour, and the average of these blood
pressure values was determined. Mean arterial pressure was
calculated as the sum of diastolic pressure and one third of the
pulse pressure. Simultaneously the heart rate was determined.
Subsequently, arterial and venous compliance were measured.
Finally, echo-Doppler cardiographic measurements were per-
formed.
Arterial distensibility and compliance
The carotid, femoral and brachial arteries were studied using a
non-invasive ultrasound wall movement detector system. This
system, developed by Hoeks et al., has been described in detail
[10]. In brief, it consists of a conventional ultrasound imager
(Ultramark-V, ATL, Bothell, USA), with a 7.5 megahertz trans-
ducer, a data acquisition system and a personal computer. The
transducer was positioned on the skin surface perpendicularly to
the artery under study. An ultrasonic gel was used to optimize
signal transduction. Subsequently, the arterial diastolic diameter
(Dd), with a precision of approximately 10 j.m, and the arterial
wall distension (SD), with a precision of less than 10 tim, were
recorded during 5 seconds.
Simultaneously with the vessel movement registration, blood
pressure was measured every two minutes with an automated
device (Dinamap, Tampa, FL, USA). The averages of these blood
pressures and pulse pressures (P) were calculated.
From the arterial diameter, the change in diameter during the
heart cycle (distension), and the pulse pressure, arterial distensi-
bility and compliance were calculated according to the following
equations:
DC (distensibility coefficient) = (2D/Dd)/P, 103/kPa (1)
CC (compliance coefficient) = (rDdthD)/2P, mm2/kPa (2)
which means that CC can be calculated by multiplying DC and the
cross sectional area of the vessel lumen [11].
The intraobserver variability of the diameter measurements was
determined and appeared to be less than 10% in the carotid artery
and between 10% and 15% in the femoral and brachial arteries
[12]. All measurements were performed by the same experienced
investigator.
Venous compliance
Venous compliance was measured by strain gauge plethysmog-
raphy (Periflow, Janssen Scientific Instruments, Beerse, Belgium)
with direct intravenous pressure measurements. An antecubital
vein was canulated (Venflon, internal diameter 1 mm) and the
canula was connected to a pressure dome (Hewlett Packard), that
was positioned at right atrial level, approximately 5 cm under the
sternal angle. Venous pressure was displayed on a Hewlett
Packard monitor as well as graphically. An inflatable cuff was
applied to the upper part of the cannulated arm, and a mercury-
filled strain-gauge was positioned around the forearm at one third
of the forearm length from the lateral epicondyl. The plethysmo-
graph and the pressure monitor were subsequently calibrated and
a stabilization period of 15 minutes was taken into account.
Subsequently, the arm cuff was inflated at a cuff pressure of 25 mm
Hg and kept inflated during three minutes. This time interval was
chosen to obtain stable values for arm volume and intravenous
pressure. Thereafter, the cuff was deflated for two minutes to
prevent accumulation of interstitial fluid due to capillary filtration.
The change in arm volume and intravenous pressure were both
measured after cuff deflation, in order to exclude any effect of
capillary filtration on the obtained volume-pressure ratio. Subse-
quently, the procedure was repeated at stepwise increasing cuff
pressures of 30, 35, 40 and 45 mm Hg, which yielded 5 volume-
pressure ratios. These ratios were used in a linear regression
analysis to obtain the volume-pressure relationship and thereby
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an estimate of venous compliance, since venous compliance is
defined as the slope of this relationship [131.
The between-day coefficient of variation of this technique was
15.5% [14].
Echo-Doppler cardiography
The measurements were performed using a Hewlett Packard
sonos 100 echo-Doppler cardiograph, with the subjects in the
partial left lateral decubitus position. Parasternal B-mode short
and long axis images were obtained to provide reference points
for subsequent M-mode investigation (3.5 MHz transducer). Left
ventricular internal diameter (LVID), interventricular septum
(IVS) and left ventricular posterior wall thickness (LVPW) were
measured distally to the tips of the mitral valve at the onset of the
QRS complex on the ECU, during three consecutive cardiac
cycles. Average values were determined. Left ventricular mass
(LVM) was calculated according to the formula of Devereux:
LVM = 1.04 * [(IVS + LVID + LVPW)3 — LVID3) — 13.6.
The reliability of this method has been amply demonstrated [15,
16]. Left ventricular hypertrophy was considered to be present
when the left ventricular mass index exceeded 125 g/m2 [17].
In order to obtain cardiac stroke volume, ascending aortic
blood flow velocity was measured using a continuous wave
Doppler system with a 10 megahertz transducer, positioned at the
apex, while the aortic diameter was determined by means of
B-mode echocardiography, positioned at the third or fourth
intercostal space at the left sternal edge. Cardiac output was
calculated by multiplying stroke volume with heart rate. It has
been shown, that when performed by a skilled investigator, the
results of this method correlate well with other (invasive and
non-invasive) techniques [18]. In our clinic, the intra- and inter-
observer variability of this method to assess stroke volume has
been established to be 9% and 11%, respectively [19]. Cardiac
output, stroke volume and left ventricular mass were normalized
for body surface area.
Data analysis
Data were first checked for normality. Because no great dis-
crepancies were found in the data, differences in characteristics of
the investigated groups were tested by means of independent
Student t-tests. Repeated measurement multivariate analysis of
variance was used to analyze treatment effects.
Doubly multivariate analysis of variance was done to ascertain
the elimination of blood pressure as confounding factor in the
relation between type of treatment and arterial measurements
[20]. Doubly multivariate analysis of variance is an analysis of
variance which handles variates in two ways: first, each variate is
repeated in time, and second, to that there is more than one
measure that is repeated [21]. The design used in the study
concerning doubly multivariate analysis can be characterized as a
double within-factors design. The first within-factor is "time"
having four catagories; the second one is "clinical outcome" such
as arterial compliance and blood pressure. Eventually the design
becomes a mixed one, because the treatment factor (enalapril,
felodipine or placebo) and the patient groups (sodium-sensitive
and sodium-resistant) are clearly between factors.
Blood pressure cannot be analyzed as a co-variant, for it tends
to change in time. Therefore we had to include it as a repeated
Table 1. Patient characteristics at the beginning of the study
X
Sodium
sensitive P
Sodium
resistant
N 17 28
Age 41±6 0.41 40±6
Body surface area 2 0.2 0.74 2 0.2
Systolic blood pressure 155 13 0.43 153 16
mm Hg
Diastolic blood pressure 87 6 0.42 85 8
mm Hg
MAP mm Hg 110±7 0.48
HR bpn 67 13 0.20
108 10
63 10
Abbreviations are: MAP, mean arterial pressure; HR, heart rate. Data
are mean SD.
measurement within the design mentioned above. The co-vari-
ance between blood pressure and vascular compliance could be
analyzed in this way given the treatment categories.
All data analyses were done using SPSS-pc programs; P 0.05
was regarded as statistically significant.
Results
Sodium-sensitivity status
Two subjects were excluded because of non-compliance to the
diet; the difference in sodium excretion between low and high salt
regimens was smaller than 150 mmol/day in these subjects.
According to the definition used in this study, 17 borderline
hypertensive patients were classified as being salt-sensitive and 28
as being salt-resistant. Sodium and potassium excretion at the end
of the high and low salt diets was comparable for the two groups.
The difference in mean arterial pressure at the end of the low
and high salt diets was 12 5 (range 8 to 22) mm Hg for the sensitive
and —2 7 (range —16 to 5) mm Hg for the sodium-resistant group.
The weight gain after the high sodium diet as compared to the low
sodium diet was 1.7 1 kg for the sodium-sensitive group and 0.9
1 kg (P = 0.08) for the sodium-resistant group.
Subject characteristics
Table 1 shows characteristics of the sodium-sensitive borderline
hypertensive (SS) and the sodium-resistant borderline hyperten-
sive groups (SR) at the start of the study. There were no
significant differences in age or body surface area between the
groups. The estimated duration of hypertension was seven years in
both groups. Systolic and diastolic pressures, as well as mean
arterial pressures were comparable in the groups. Likewise, the
heart rates did not differ between the groups.
Five sodium-sensitive borderline hypertensives were treated
with enalapril (SS-E), five with felodipine (SS-F) and seven with
placebo (SS-P), while 11 sodium-resistant subjects had enalapril
(SR-E), 10 felodipine (SR-F) and seven placebo (SR-P) during
the treatment period. The two excluded subjects were initially
grouped as SR-P. The average decrease in mean arterial pressure
after six months of treatment was SS-E:14 (range 2 to 28) mm Hg,
SS-F:11 (1 to 25) mm Hg, SS-P:3 (—6 to 16) mm Hg in the
sodium-sensitive group and SR-E:12 (—5 to 33) mm Hg, SR-F:6
(—7 to 21) mm Hg, SR-P:5 (—25 to 24) mm Hg in the resistant
group (NS).
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Table 2 gives details about the sodium-sensitive group. The
improvement in femoral and brachial artery compliance was due
to increased distension rather than increased diameter. The
improvement of the elastic properties of the femoral and brachial
artery reached a maximum after six months of treatment and fell
towards baseline values in the wash-out period. Baseline compli-
ance of the femoral artery in the enalapril-treated sodium-
sensitive subjects tended to be somewhat lower than that of the
felodipine treated group, although the difference was not statisti-
cally significant. In the other muscular artery under study (bra-
chial artery) baseline values are very comparable. Felodipine did
not induce an improvement of the elastic properties of the
femoral and brachial arteries (Fig. 3 and 4). Since pulse pressure
was not significantly influenced by either enalapril or felodipine
[mean decrease in pulse pressure after 6 months: SS-E:2 (range
—7 to 10) mm Hg, SS-F:3 (range —4 to 15) mm Hg, SS-P:3 (range
—6 to 9) mm Hg] and was not significantly different between the
groups, a higher pulse pressure cannot be held responsible for the
increased distension of the femoral and brachial arteries upon
enalapril.
Since the enalapril induced reduction in blood pressure per se
may induce improvement of distensibility of the arteries, a doubly
multivariate analysis of variance was performed in order to
evaluate whether the improvement of femoral distension was
entirely achieved through a decrease in blood pressure, or
whether enalapril exerts additional effects independently of blood
pressure. This analysis indicated that the treatment effect of
enalapril on both femoral and brachial distension remained
significant when mean blood pressure values were taken into
account, suggesting an effect of enalapril on arterial distension
independent from its blood pressure lowering action (femoral
artery P = 0.01, brachial artery P = 0.02).
Venous compliance
Venous compliance was comparable and only slightly below
normal in the sodium-sensitive and sodium-resistant groups at the
start of the study. Pharmacological intervention with either ena-
lapril or felodipine, did not induce changes that were significantly
different from placebo.
Echo-Doppler cardiography
Fig. 1. Effects of treatment on arterial compliance in the sodium resistant
group. A. Carotid artery. B. Femoral artery. C. Brachial artery. Symbols
are: () 0 months; () 3 months; (P4) 6 months; ( ) 9 months.
Arterial distensibility and compliance
Treatment with enalapril, felodipine or placebo did not signif-
icantly influence arterial diameter and distension of the three
investigated arteries of the sodium-resistant group. Pulse pressure
was not significantly altered during the treatment period. As a
consequence arterial compliance was not improved by the phar-
macological agents in the resistant group (Fig. 1).
Carotid artery compliance did not change significantly in the
enalapril or felodipine treated sodium-sensitive subjects (Fig. 2).
In contrast, femoral and brachial artery compliance improved
significantly in the enalapril treated sodium-sensitive subjects.
Although left ventricular mass index tended to be somewhat
larger in the sodium-sensitive group than in the resistant one after
the initial investigation (SS: 109 25 g/m2, SR: 95 37 gIm2,
P = 0.2), the slightly elevated blood pressure in the investigated
groups has not yet led to left ventricular hypertrophy. In the entire
group of borderline hypertensive subjects, after adjustment for
blood pressure, significant inverse correlations were found be-
tween large artery distension and left ventricular mass index
(carotid: r =
—0.64, P < 0.0001, femoral: r = —0.43, P = 0.013,
brachial r =
—0.31, P = 0.022). Pharmacological intervention did
not significantly influence left ventricular mass, stroke index or
cardiac index.
Discussion
Six months of enalapril treatment induced a significant im-
provement of the femoral and brachial artery distensibility and
compliance in the sodium-sensitive, but not in the sodium-
resistant borderline hypertensive group. This improvement was
achieved by an effect of enalapril on the vascular distension rather
1.00
0.80
0.60
E 0.40
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0.20
0.00
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1.20
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E 0.600
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A
B
0.50
0.40
0.30
E 0.2000 0.10
0.00
Enalapril Felodipine Placebo
Enalapril Felodipine Placebo
Enalapril Felodipine Placebo
Fig, 2. Effects of treatment on the compliance of
the carotid arteiy in the sodium sensitive group.
Symbols are as in Figure 1.
Enalapril Felodipine Placebo
—E +E --F +F —P +P
SystolicBPminHg 151±5 134±14 156±12 148±15 156±13 144±17
Diastolic BP mm Hg 84 7 72 13 91 7 78 10 87 4 87 8
PRA ngImlhr 1.0 0.6 7.9 5 1.0 0.6 1.4 0.8 1.1 0.7 0.7 0.4
UN mmol/24 hr 122 38 130 40 128 24 132 38 136 21 119 36
Data are mean Abbreviations are: PRA, plasma renin activity; UN, urinary sodium excretion; (—) before and (+) after six months of treatment
in sodium sensitive subjects.
than by enlargement of the vascular diameter. The effect of
enalapril on the distension of the two arteries reached a maximum
after six months of treatment and returned to baseline levels at
the end of the wash-out period. Furthermore, doubly multivariate
analysis suggested that the improvement of femoral and brachial
artery distention could not be explained by the decrease in blood
pressure only. Thus, although the investigated groups are small,
these data suggest that enalapril chronically modulates the visco-
elastic properties of the femoral and brachial artery wall in
sodium-sensitive subjects. Furthermore, the fact that enalapril did
not appreciably influence large artery compliance in the sodium-
resistant group may favour the hypothesis that the renin-angio-
tensin system is involved in determining the difference between
sodium-sensitive and sodium-resistant borderline hypertensive
subjects as far as large artery compliance is concerned.
The compliance of the carotid artery was not significantly
altered in the sodium-sensitive group. It may be expected that
enalapril, through its relaxant effect on vascular smooth muscle,
has a more pronounced effect on muscular arteries such as the
femoral and brachial arteries, than on elastic arteries, such as the
carotid.
ACE inhibitors are known to exert a beneficial effect on arterial
compliance in established and experimental hypertension [22—24].
Information on effects of ACE inhibition on large arteries in
borderline hypertensive subjects is not widely available. Unlike
the arterial dilatory effect of both enalapril [21] and felodipine
[25] in essential hypertensives, no such effect was present in our
borderline hypertensive population. The positive effect on com-
pliance in this long-term experiment was entirely achieved
through an increase in arterial distension.
Apart from a vasodilatory effect, ACE inhibitors are known to
interfere with growth factors [26] and may induce regression of
hyperthrophy of arterial walls.
Although blood pressure, pulse pressure, stroke and cardiac
index were equally influenced by enalapril and felodipine treat-
ment in all investigated groups, felodipine did not alter large
artery compliance in the sodium-sensitive group. This suggests
that the positive effect of enalapril and the lack of effect of
felodipine on femoral and brachial distension are not related to
changes in hemodynamics.
However, one has to keep in mind that something must have
changed in the arterial wall of sodium-sensitive subjects under
felodipine treatment, otherwise one would have expected a pas-
sive decline in arterial diameter upon the blood pressure reduc-
tion. Counterregulatory mechanisms may prevent this diameter
reduction, thereby contributing to the lack of improvement in the
compliance in the felodipine-treated sodium-sensitive subjects.
A critique on the vessel wall movement detector method, as
used in the present study, is that pulse pressure was measured in
the brachial rather than in the carotid and femoral arteries. The
calculations of distensibility and compliance as performed in this
study are only valid if the brachial pulse pressure is representative
for that of the carotid and femoral arteries. Although we assume
that such is the case, there can be a mismatch, especially when
early pulse wave reflections ('shoulders') are present in the
distension curves. Though not discussed in the present paper, at
the onset of the study 41% of the sodium-sensitive subjects and
36% of the resistant subjects had 'shouldered' carotid distension
curves, while no overt early pulse wave reflections were detected
in the brachial and femoral arteries. Since there were no great
discrepancies in the distribution of shouldered curves over the
groups, we assumed a systematic error when we used brachial
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Table 2. Sodium sensitive group characteristics
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Fig. 3. Effects of treatment in the sodium sensitive groups on femoral artety diameter (A), distension (B), distensibility (C), and compliance (D). Symbols are
as in Figure 1.
artery pulse pressure in the calculations of carotid and femoral
compliance. Moreover, the 5% higher occurrence of 'shoulders' in
the sensitive group may indicate that the calculations based on
brachial pulse presure overestimate the actual compliance of the
carotid artery in the sensitive group. Thus, the actual difference in
carotid compliance between the sensitive and resistant group may
be even more pronounced.
The reason that we used brachial artery pulse pressure in the
calculations of carotid and femoral distensibility and compliance
is that non-invasive methods to assess pulse pressure in the
femoral and carotid arteries are scarce. Applanation tonometry
may be a candidate [27], but technical difficulties and problems of
reproducibility must be resolved. Taken together, we think that
using brachial pulse pressure as a model for carotid and femoral
pulse pressures induces a similar and systematic error in both
groups, at least in the untreated situation.
Treatment with two antihypertensive agents, however, compli-
cates the situation since they may induce differential effects on
various macro- and microvascular beds, thereby specifically influ-
encing pulse wave reflections. The error that is induced by using
the brachial artery pulse pressure in the calculation of carotid and
femoral artery compliance may no longer be a systematic one that
is comparable in the sodium-sensitive and sodium-resistant
groups.
Aware of this problem, we again studied distension curves in
the sodium-sensitive subjects that were treated during six months
with either enalapril or felodipine. Since there were no shoul-
dered distension curves in the femoral and brachial arteries, we
concluded that the difference in arterial wall properties that was
found after six months of treatment with enalapril or felodipine in
two sodium-sensitive groups may therefore be valid.
Previously, we found that despite a slight, but similar reduction
in venous compliance in sodium-sensitive and -resistant border-
line hypertensive subjects, the differences were not statistically
significant from normal. Consequently, no major effects of treat-
ment on venous compliance were expected in the present study.
Indeed, venous compliance was not appreciably modified by
antihypertensive treatment in our subjects. Similarly, no effect of
enalapril or felodipine treatment on left ventricular mass was
found.
In conclusion, six months of enalapril treatment induced a
significant dose-dependent improvement of femoral and brachial
artery distention and compliance in sodium-sensitive borderline
hypertensive subjects that could not be explained by changes in
blood pressure, pulse pressure or cardiac index.
No effects of enalapril were seen in the carotid artery of the
sodium-sensitive subjects, suggesting inhomogeneity in the re-
sponse of large arteries to enalapril treatment. Felodipine did not
induce significant changes in the arterial compliance of sodium-
sensitive subjects. As was expected, neither drug modified arterial
compliance in sodium-resistant subjects or venous compliance in
the sensitive and the resistant groups.
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Fig. 4. Effects of treatment in the sodium sensitive group on brachial artely diameter (A), distension (B), distensibility (C), and compliance. (B). Symbols are
as in Figure 1.
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